Grant H. Skrepnek, Ph.D., R.Ph.

Professor

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47105

Fax (4050 271-6430

Office CPB 214

Email grant-skrepnek@ouhsc.edu

Summary

I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.


Research

Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.



Publications & Presentations

<< 1 2 3 4 5 6 7 > >>
    16. Schwier N C, Tran N T, Skrepnek G H. Clinical and economic outcomes associated with hospitalizations for acute idiopathic pericarditis in the United States. Heart & Lung. 2021; 50 : 825-31

    17. Dickson M C, Nguyen M M, Skrepnek G H. Diabetic supply utilization among Oklahoma Medicaid members [Legislative Report]. Oklahoma Health Care Authority. 2021

    18. Nguyen M, Dickson M C, Skrepnek G H. Medicaid Value-Based Contract (VBC) in partial-onset seizure disorder [Legislative Report]. Oklahoma Health Care Authority. 2021

    19. Nguyen M M, Dickson M C, Skrepnek G H. Medicaid Value-Based Contract (VBC) in primary generalized tonic-clonic seizures and involving adjunctive agents for the treatment of partial-onset seizures [Legislative Report]. Oklahoma Health Care Authority. 2021

    20. Dickson M C, Nguyen M M, Skrepnek G H. Medicaid Value-Based Contract (VBC) in the prevention of migraine [Legislative Report]. Oklahoma Health Care Authority. 2021

<< 1 2 3 4 5 6 7 > >>



Grants

1 2 3 4 >>
    1. [Cooperative Agreement] Oklahoma State Department of Health, A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes – 2023 (DP-23-0020, FAIN #NU58DP007376, CFDA #93.988 (Cooperative Agreements for State-Based Diabetes Control Programs and Evaluation of Surveillance Systems). . CDC. Start Date: 2023. End Date: 2024.

    2. [Cooperative Agreement] Oklahoma State Department of Health, Chronic Disease Prevention Program: The National Cardiovascular Health Program (DP-23-0004, FAIN #NU58DP007471, CFDA #93.426 - The National Cardiovascular Health Program, CDV/Heart. CDC. Start Date: 2023. End Date: 2024.

    3. HIV Adherence Services. Start Date: 2022. End Date: 2023.

    4. Patterns of Care, Outcomes, and Barriers to Treatment Success or Vaccination Associated with Adult Community-Acquired Pneumonia in Medicaid. Misc Non-Federal. Start Date: 2021. End Date: 2022.

    5. [Service Agreement] Opioid Use Under Oklahoma Senate Bill 848.. Non-federal. Start Date: 2020. End Date: 2020.

1 2 3 4 >>



Awards and Honors


no results

Education


no results

Administrative Assignments

                                                
     1. Role: Director. Scope: Department. Date: 2019.
                                                
     2. Role: Director. Scope: Department. Description: Interim Director & Director of Academic Research. Date: 2019.